IBM Watson Health has announced an extension through June 2019 of its collaboration with the U.S. Department of Veterans Affairs (VA) to help treat veterans with cancer using artificial intelligence (AI).
The partners use the Watson cognitive computing platform to inform the delivery of personalized treatment plans by the VA's oncologists. This requires researchers and clinicians to sequence patients' DNA to locate likely cancer-causing mutations and determine strategies to target those mutations.
AI can help oncologists interpret genomic data faster and with less difficulty.
"It is incredibly challenging to read, understand, and stay up-to-date with the breadth and depth of medical literature and link them to relevant mutations for personalized cancer treatments," says IBM Watson Health's Kyu Rhee. "This is where AI can play an important role in helping to scale precision oncology."
View Full Article
Abstracts Copyright © 2018 Information Inc., Bethesda, Maryland, USA